About Bio-Rad
For 30 years, AbD Serotec has been one of the world’s leading antibody manufacturers supplying over 15,000 antibodies, kits and accessories.
We pride ourselves on providing great customer support for all the products and services we supply so please contact us with any questions on their use or the results you can expect. We can even help source products not currently available or develop them to your specification using our custom services team.
AbD Serotec has an ISO 9001 certified production facility in Kidlington, near Oxford, UK. This facility is AbD Serotec's global headquarters, and supports our other center in Raleigh, North Carolina, USA. Our unique HuCAL custom monoclonal generation services are performed at our ISO 9001 certified laboratories in Puchheim, near Munich in Germany.
In January 2013, AbD Serotec became part of Bio-Rad Laboratories, Inc. Bio-Rad has played a leading role in the advancement of scientific discovery for 60 years by providing a broad range of innovative tools and services to the life science research and clinical diagnostics markets.
- Founding: 1952
- Focus : Manufacturer
- Employees: 51-200
- Industry : Biotechnology
Product portfolio of Bio-Rad
Similar companies
Here you will find Bio-Rad AbD Serotec Ltd
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
